dapsone has been researched along with sulfamethoxazole in 71 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 29 (40.85) | 18.7374 |
1990's | 15 (21.13) | 18.2507 |
2000's | 20 (28.17) | 29.6817 |
2010's | 7 (9.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Queener, SF | 1 |
Ayscue, R; Gannett, PM; Locuson, CW; Tracy, TS | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Kakande, I | 1 |
Havas, L | 1 |
Karwacki, JJ; Shanks, GD; Suriyamongkol, V; Watanasook, C | 1 |
Kwok, RY; Lambertus, MW; Mulligan, ME | 1 |
Montgomery, AB | 1 |
Benowitz, NL; Jacob, P; Lee, BL; Medina, I; Mills, J; Wofsy, CB | 1 |
Kovacs, JA; Masur, H | 1 |
Fischl, MA | 1 |
Hauptman, SP; Wordell, CJ | 1 |
Clarkson, AB; Rosenberg, C; Williams, DE | 1 |
Cushion, MT; Foy, JM; Kim, CK; Linke, MJ; Walzer, PD | 1 |
Hughes, WT | 1 |
Hopewell, PC; Hughes, WT; Leoung, G; Medina, I; Mills, J; Wofsy, C | 1 |
el Sid, MA; Gumaa, SA; Mahgoub, ES | 1 |
Hughes, WT; Jacobus, DP; Smith, BL | 1 |
Andrade, R; Bonifaz, A; Messina, M; Saúl, A | 1 |
Himmunknan, P; Piamphongsant, T; Sirimachan, S | 1 |
Edelson, PJ; Friedman-Kien, A; Metroka, CE | 1 |
Catterall, JR; Potasman, I; Remington, JS | 1 |
Cushion, MT; Linke, MJ; Stanforth, D; Walzer, PD | 1 |
Vischer, WA | 1 |
Mahgoub, ES; Murray, IG | 1 |
Peters, W | 1 |
Jackson, EA; McLeod, DC | 1 |
Hughes, WT; Smith, BL | 1 |
Biagini, RE; Martínez, TE; Museli, A; Sarmiento Villa, H | 1 |
Dekio, S; Moriyasu, S; Takagaki, K; Yamasaki, R | 1 |
Hughes, WT; Killmar, JT; Oz, HS | 1 |
Glick, M; Muzyka, BC | 1 |
Foy, J; Steele, P; Walzer, PD; White, M | 1 |
Fraser-Smith, EB; Freitas, VR; Matthews, TR | 1 |
Cirioni, O; Giacometti, A; Scalise, G | 1 |
Yeo, AE | 1 |
Brun-Pascaud, M; Chau, F; Derouin, F; Girard, PM | 1 |
Bellevue, FH; Reilly, TP; Svensson, CK; Woster, PM | 1 |
Reilly, TP; Svensson, CK; Woster, PM | 1 |
Meshnick, SR | 1 |
Crane, LR; Farrough, MJ; MacArthur, RD; Reilly, TP; Svensson, CK; Woster, PM | 1 |
Antin, JH; Bernardo, MV; King, C; Vasconcelles, MJ; Weller, EA | 1 |
Lin, X; Wu, S | 1 |
Elmahallawy, M; Horsfield, C; Praveen, CV; Terry, RM | 1 |
Igarashi, Y; Ishiguro, N; Kawashima, M; Okamoto, R; Shishido, E; Yamada, M | 1 |
Cynamon, MH; Destefano, MS; Thielking, DM; Yeo, AE | 1 |
Atzori, C; Benfield, T; Crothers, K; Helweg-Larsen, J; Huang, L; Miller, R; Rabodonirina, M | 1 |
Gaspari, AA; Reilly, TP; Roychowdhury, S; Svensson, CK; Vyas, PM | 1 |
Amschler, J; Behrens, D; Clement, B; Havemeyer, A; Matschke, K; Wolf, S | 1 |
Roychowdhury, S; Svensson, CK; Vyas, PM; Woster, PM | 1 |
Roychowdhury, S; Svensson, CK; Vyas, PM | 2 |
Khan, FD; Nemes, R; Roychowdhury, S; Svensson, CK; Vyas, PM; Woster, PM | 1 |
Bhaiya, P; Doll, MA; Hein, DW; Roychowdhury, S; Svensson, CK; Vyas, PM | 1 |
Hines, RN; Koukouritaki, SB; Krueger, SK; Nauseef, WM; Roychowdhury, S; Svensson, CK; Vyas, PM; Williams, DE | 1 |
Blaisdell, J; Goldstein, JA; Hines, RN; Khan, FD; Lamba, J; Munson, KL; Prisinzano, TE; Roychowdhury, S; Schuetz, EG; Svensson, CK; Vyas, PM | 1 |
Fernley, RT; Iliades, P; Macreadie, I | 1 |
Gaspari, AA; Khan, FD; Svensson, CK; Vyas, PM | 1 |
Kamchonwongpaisan, S; Sirawaraporn, W; Talawanich, Y; Yuthavong, Y | 1 |
8 review(s) available for dapsone and sulfamethoxazole
Article | Year |
---|---|
New drug developments for opportunistic infections in immunosuppressed patients: Pneumocystis carinii.
Topics: Animals; Drug Design; Humans; Immunosuppression Therapy; Molecular Structure; Opportunistic Infections; Pneumonia, Pneumocystis; Structure-Activity Relationship | 1995 |
Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome: pathophysiology, therapy, and prevention.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; Dapsone; Diet; Drug Combinations; Humans; Oxygen Inhalation Therapy; Pentamidine; Pneumonia, Pneumocystis; Sulfamethoxazole; Trimethoprim | 1989 |
Pneumocystis carinii pneumonia: therapy and prophylaxis.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Dapsone; Drug Combinations; Drug Therapy, Combination; Humans; Pentamidine; Pneumonia, Pneumocystis; Pyrimethamine; Quinazolines; Recurrence; Sulfadiazine; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Trimetrexate | 1988 |
Treatment and prophylaxis of Pneumocystis carinii pneumonia.
Topics: Acquired Immunodeficiency Syndrome; Adrenal Cortex Hormones; Antiprotozoal Agents; Clinical Trials as Topic; Dapsone; Drug Combinations; Humans; Pentamidine; Pneumonia, Pneumocystis; Quinazolines; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Trimetrexate; Zidovudine | 1988 |
Prevention of Pneumocystis carinii pneumonia.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; Dapsone; Drug Combinations; Humans; Pentamidine; Pneumonia, Pneumocystis; Pyrimethamine; Recurrence; Sulfadoxine; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
Summary of recent abstracts. 3. Malaria.2.
Topics: Animals; Carbon Isotopes; Chloroquine; Dapsone; DNA; Drug Resistance, Microbial; Humans; Malaria; Orotic Acid; Plasmodium; RNA; Sulfamethoxazole | 1973 |
Pneumocystis carinii infection in bilateral aural polyps in a human immunodeficiency virus-positive patient.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Dapsone; Ear Neoplasms; Ear, Middle; Humans; Male; Pneumocystis Infections; Polyps; Sulfamethoxazole; Tomography, X-Ray Computed; Trimethoprim | 2002 |
Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance.
Topics: Anti-Infective Agents; Dapsone; Dihydropteroate Synthase; Drug Resistance, Fungal; Gene Expression; Humans; Mutation; Pneumocystis carinii; Pneumonia, Pneumocystis; Risk Factors; Sulfamethoxazole; Sulfones; Trimethoprim | 2004 |
7 trial(s) available for dapsone and sulfamethoxazole
Article | Year |
---|---|
Proguanil/sulfamethoxazole malaria chemoprophy-laxis on the Thai-Cambodian border.
Topics: Adult; Animals; Cambodia; Dapsone; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Male; Military Personnel; Patient Compliance; Plasmodium falciparum; Proguanil; Pyrimethamine; Sulfamethoxazole; Thailand | 1991 |
Dapsone, trimethoprim, and sulfamethoxazole plasma levels during treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome (AIDS). Evidence of drug interactions.
Topics: Acetylation; Acquired Immunodeficiency Syndrome; Adult; Dapsone; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Phenotype; Pneumonia, Pneumocystis; Prospective Studies; Random Allocation; Sulfamethoxazole; Trimethoprim | 1989 |
Treatment and prophylaxis of Pneumocystis carinii pneumonia.
Topics: Acquired Immunodeficiency Syndrome; Adrenal Cortex Hormones; Antiprotozoal Agents; Clinical Trials as Topic; Dapsone; Drug Combinations; Humans; Pentamidine; Pneumonia, Pneumocystis; Quinazolines; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Trimetrexate; Zidovudine | 1988 |
Pneumocystis carinii pneumonia in the patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Animals; Bronchoscopy; Clinical Trials as Topic; Dapsone; Drug Combinations; Drug Therapy, Combination; Eflornithine; Humans; Male; Ornithine; Pentamidine; Pneumocystis; Pneumonia, Pneumocystis; Pyrimethamine; Sulfadiazine; Sulfamethoxazole; Therapeutic Irrigation; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1985 |
Comparison of the in vitro cytotoxicity of hydroxylamine metabolites of sulfamethoxazole and dapsone.
Topics: Cell Survival; Dapsone; Drug Hypersensitivity; Erythrocytes; Humans; Hydroxylamine; In Vitro Techniques; Leukocytes, Mononuclear; Linear Models; Logistic Models; Sulfamethoxazole | 1998 |
Is hydroxylamine-induced cytotoxicity a valid marker for hypersensitivity reactions to sulfamethoxazole in human immunodeficiency virus-infected individuals?
Topics: Adult; Anti-Infective Agents; Benzoxazoles; Biomarkers; Cell Separation; Cell Survival; Dapsone; Drug Hypersensitivity; Female; Fluorescent Dyes; HIV Infections; Humans; Hydroxylamine; Male; Middle Aged; Monocytes; Quinolinium Compounds; Sulfamethoxazole | 1999 |
Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosol Propellants; Aged; Antifungal Agents; Bone Marrow Transplantation; Cohort Studies; Combined Modality Therapy; Dapsone; Drug Evaluation; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Infections; Male; Middle Aged; Pentamidine; Pneumocystis Infections; Retrospective Studies; Sulfamethoxazole; Survival Rate; Trimethoprim | 2000 |
57 other study(ies) available for dapsone and sulfamethoxazole
Article | Year |
---|---|
Use of simple docking methods to screen a virtual library for heteroactivators of cytochrome P450 2C9.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C9; Dapsone; Databases, Factual; Enzyme Activators; Enzyme Inhibitors; Flurbiprofen; Humans; Models, Molecular; Molecular Structure; NADPH-Ferrihemoprotein Reductase; Quantitative Structure-Activity Relationship; Rats | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Treatment of mycetoma.
Topics: Dapsone; Drug Combinations; Drug Therapy, Combination; Humans; Mycetoma; Streptomycin; Sulfamethoxazole; Trimethoprim | 1977 |
Treatment of mycetoma with a combination of dapsone and co-trimoxazole.
Topics: Adult; Dapsone; Drug Combinations; Drug Therapy, Combination; Humans; Male; Mycetoma; Sulfamethoxazole; Trimethoprim | 1979 |
[The treatment of various deep mycoses (South American blastomycosis, nocardiosis, actinomycetoma) with the drug combination sulfamethoxazole+trimethoprim (bactrim, septrin). Review of the literature].
Topics: Actinomycetales; Actinomycetales Infections; Blastomyces; Blastomycosis; Dapsone; Drug Combinations; Drug Synergism; Histoplasma; Histoplasmosis; Mycoses; Nocardia; Nocardia Infections; South America; Sulfamethoxazole; Trimethoprim | 1975 |
In vitro susceptibilities of oxacillin-resistant Staphylococcus aureus to dapsone and sulfamethoxazole alone and in combination with trimethoprim.
Topics: Dapsone; Enterococcus faecalis; Escherichia coli; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Staphylococcus aureus; Sulfamethoxazole; Trimethoprim | 1990 |
Treatment of Pneumocystis carinii pneumonia.
Topics: Acquired Immunodeficiency Syndrome; Dapsone; Drug Combinations; Folic Acid Antagonists; Humans; Methylprednisolone; Pentamidine; Pneumonia, Pneumocystis; Quinazolines; Recurrence; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Trimetrexate | 1987 |
Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adrenal Cortex Hormones; Adult; Anti-Infective Agents; Dapsone; Drug Combinations; Eflornithine; Humans; Male; Pentamidine; Pneumonia, Pneumocystis; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
Efficacy of DL-alpha-difluoromethylornithine in a rat model of Pneumocystis carinii pneumonia.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Dapsone; Diminazene; Disease Models, Animal; Drug Combinations; Eflornithine; Female; Immunosuppression Therapy; Pneumonia, Pneumocystis; Random Allocation; Rats; Rats, Inbred Strains; Sulfamethoxazole; Suramin; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
Inhibitors of folic acid synthesis in the treatment of experimental Pneumocystis carinii pneumonia.
Topics: Animals; Dapsone; Drug Therapy, Combination; Folic Acid Antagonists; Immunosuppression Therapy; Male; Pneumonia, Pneumocystis; Pyrimethamine; Pyrimidines; Rats; Rats, Inbred Strains; Sulfadiazine; Sulfadoxine; Sulfamethoxazole; Trimethoprim | 1988 |
Comparison of dosages, intervals, and drugs in the prevention of Pneumocystis carinii pneumonia.
Topics: Amidines; Animals; Anti-Infective Agents; Dapsone; Drug Administration Schedule; Drug Combinations; Immunosuppression Therapy; Male; Pentamidine; Pneumonia, Pneumocystis; Rats; Rats, Inbred Strains; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
Dapsone treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Dapsone; Drug Therapy, Combination; Humans; Male; Pentamidine; Pneumonia, Pneumocystis; Sulfamethoxazole; Trimethoprim | 1988 |
Mycetoma of the head and neck.
Topics: Actinomycetales Infections; Adolescent; Adult; Child; Dapsone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mitosporic Fungi; Mycetoma; Radiography; Skull; Streptomycin; Sudan; Sulfamethoxazole; Temporomandibular Joint; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1986 |
Successful treatment and prevention of murine Pneumocystis carinii pneumonitis with 4,4'-sulfonylbisformanilide.
Topics: Animals; Dapsone; Dexamethasone; Drug Combinations; Pneumonia, Pneumocystis; Rats; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1986 |
Mycetoma due to Nocardia caviae.
Topics: Dapsone; Drug Combinations; Humans; Male; Middle Aged; Mycetoma; Nocardia Infections; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
Juvenile blistering diseases: the problems of diagnosis and treatment.
Topics: Autoantibodies; Child; Child, Preschool; Complement C3; Dapsone; Dermatitis Herpetiformis; Diagnosis, Differential; Drug Combinations; Female; Fluorescent Antibody Technique; Humans; Immunoglobulin A; Immunoglobulin G; Infant; Male; Prednisolone; Skin Diseases, Vesiculobullous; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1986 |
Dapsone, trimethoprim-sulfamethoxazole, and the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Dapsone; Drug Combinations; Humans; Pneumonia, Pneumocystis; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1985 |
Method of testing the susceptibility of Pneumocystis carinii to antimicrobial agents in vitro.
Topics: Animals; Cells, Cultured; Dapsone; Drug Combinations; Eflornithine; Lung; Male; Ornithine; Pentamidine; Pneumocystis; Rats; Rats, Inbred Strains; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1985 |
[Comparative study on the effect of some clinically used sulfanilamide derivatives against toxoplasmosis in the mouse].
Topics: Aminobenzoates; Animals; Dapsone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Female; Mice; Placebos; Pyrimethamine; Structure-Activity Relationship; Sulfamerazine; Sulfamethoxazole; Sulfonamides; Time Factors; Toxoplasmosis, Animal; Trimethoprim | 1973 |
Treatment of nocardiosis.
Topics: Dapsone; Folic Acid Antagonists; Humans; Nocardia Infections; Pyrimidines; Sulfamethoxazole | 1970 |
Letter: Mycetoma.
Topics: Actinomycetales Infections; Actinomycosis; Dapsone; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Immunodiffusion; Mycetoma; Streptomycin; Sudan; Sulfamethoxazole; Trimethoprim | 1974 |
Pharmacokinetics and dosing of antimicrobial agents in renal impairment, Part II.
Topics: Anti-Infective Agents; Bacitracin; Chloramphenicol; Chloroquine; Clindamycin; Dapsone; Ethambutol; Humans; Isoniazid; Kidney Diseases; Methenamine; Nalidixic Acid; Neomycin; Nitrofurantoin; Sulfadimethoxine; Sulfamethizole; Sulfamethoxazole; Sulfamethoxypyridazine; Sulfisomidine; Sulfisoxazole; Vancomycin | 1974 |
Efficacy of diaminodiphenylsulfone and other drugs in murine Pneumocystis carinii pneumonitis.
Topics: Animals; Dapsone; Disease Models, Animal; Drug Combinations; Male; Pneumonia, Pneumocystis; Rats; Rats, Inbred Strains; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1984 |
[Mycetoma in northern Argentina].
Topics: Actinomycetaceae; Adult; Aged; Argentina; Dapsone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mitosporic Fungi; Mycetoma; Nocardia; Nocardia Infections; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1983 |
Three cases of prurigo pigmentosa.
Topics: Dapsone; Humans; Male; Middle Aged; Pigmentation Disorders; Prurigo; Recurrence; Sulfamethoxazole | 1981 |
Relative potency of 10 drugs with anti-Pneumocystis carinii activity in an animal model.
Topics: Animals; Anti-Infective Agents; Atovaquone; Azithromycin; Clarithromycin; Clindamycin; Clinical Trials as Topic; Dapsone; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Humans; Naphthoquinones; Pentamidine; Pneumocystis Infections; Proguanil; Pyrimethamine; Rats; Sulfadoxine; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1994 |
Major aphthous ulcers in patients with HIV disease.
Topics: Adult; Biomarkers; CD4-CD8 Ratio; Dapsone; Ethnicity; Female; HIV Infections; Humans; Immune Tolerance; Male; Pennsylvania; Prevalence; Prospective Studies; Risk Factors; Smoking; Stomatitis, Aphthous; Sulfamethoxazole; Trimethoprim | 1994 |
Synergistic combinations of Ro 11-8958 and other dihydrofolate reductase inhibitors with sulfamethoxazole and dapsone for therapy of experimental pneumocystosis.
Topics: AIDS-Related Opportunistic Infections; Animals; Dapsone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Folic Acid Antagonists; Immunosuppression Therapy; Male; Pneumonia, Pneumocystis; Rats; Rats, Sprague-Dawley; Sulfamethoxazole; Trimethoprim | 1993 |
Efficacy of ganciclovir in combination with other antimicrobial agents against cytomegalovirus in vitro and in vivo.
Topics: Amphotericin B; Animals; Antifungal Agents; Antiviral Agents; Cells, Cultured; Cytomegalovirus Infections; Dapsone; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Ganciclovir; Humans; Ketoconazole; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Species Specificity; Sulfamethoxazole; Survival Analysis; Trimethoprim; Viral Plaque Assay | 1993 |
In-vitro activity of atovaquone, sulphamethoxazole and dapsone alone and combined with inhibitors of dihydrofolate reductase and macrolides against Pneumocystis carinii.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Atovaquone; Cells, Cultured; Dapsone; Drug Synergism; Folic Acid Antagonists; Humans; Lung; Macrolides; Microbial Sensitivity Tests; Naphthoquinones; Pneumocystis; Sulfamethoxazole | 1997 |
Direct comparison of antimalarial activity among PS-15 combination therapies by bioassay of serum samples from treated Saimiri sciureus.
Topics: Animals; Antimalarials; Atovaquone; Biological Assay; Dapsone; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Humans; Malaria, Falciparum; Naphthoquinones; Proguanil; Regression Analysis; Saimiri; Sulfamethoxazole | 1997 |
Experimental evaluation of roxithromycin combined with dapsone or sulphamethoxazole on Pneumocystis carinii and Toxoplasma gondii dual infections in a rat model.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Dapsone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Immunosuppression Therapy; Male; Pneumocystis; Pneumocystis Infections; Pyrimethamine; Rats; Rats, Wistar; Roxithromycin; Sulfamethoxazole; Toxoplasma; Toxoplasmosis, Animal | 1998 |
Methemoglobin formation by hydroxylamine metabolites of sulfamethoxazole and dapsone: implications for differences in adverse drug reactions.
Topics: Dapsone; Erythrocytes; Humans; Hydroxylamine; Hydroxylamines; Inactivation, Metabolic; Methemoglobin; Reactive Oxygen Species; Sulfamethoxazole | 1999 |
Drug-resistant Pneumocystis carinii.
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Dapsone; Dihydropteroate Synthase; Drug Resistance, Microbial; HIV-1; Humans; Pneumocystis; Pneumonia, Pneumocystis; Sulfamethoxazole | 1999 |
[A clinical study of six cases of Pneumocystis carinii pneumonia].
Topics: Acute Disease; Adult; Aged; Anemia, Hemolytic, Autoimmune; Anti-Infective Agents; Dapsone; Female; Humans; Leukemia; Lymphoma; Male; Middle Aged; Pneumonia, Pneumocystis; Positive-Pressure Respiration; Retrospective Studies; Sulfamethoxazole | 1998 |
Ofuji's disease: a report on 20 patients with clinical and histopathologic analysis.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Arm; Back; Dapsone; Facial Dermatoses; Female; Folliculitis; Foot; Humans; Immunohistochemistry; Indomethacin; Japan; Male; Mast Cells; Middle Aged; Minocycline; Prednisolone; Sulfamethoxazole; Thorax; Treatment Outcome | 2002 |
Enhanced in vitro activity of dihydrofolate reductase and dihydropteroase synthase inhibitors in combination against Nocardia spp.
Topics: Anti-Bacterial Agents; Dapsone; Dihydropteroate Synthase; Drug Synergism; Enzyme Inhibitors; Folic Acid Antagonists; Microbial Sensitivity Tests; Nocardia; Sulfamethoxazole; Tetrahydrofolate Dehydrogenase | 2003 |
Characterization of the formation and localization of sulfamethoxazole and dapsone-associated drug-protein adducts in human epidermal keratinocytes.
Topics: Acetylcysteine; Anti-Infective Agents; Antioxidants; Ascorbic Acid; Cell Line; Chromatography, High Pressure Liquid; Dapsone; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Epidermal Cells; Epidermis; Folic Acid Antagonists; Haptens; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Keratinocytes; Microscopy, Confocal; Microscopy, Fluorescence; Protein Binding; Proteins; Sulfamethoxazole | 2005 |
Reduction of sulfamethoxazole and dapsone hydroxylamines by a microsomal enzyme system purified from pig liver and pig and human liver microsomes.
Topics: Animals; Cytochrome P-450 Enzyme System; Cytochrome-B(5) Reductase; Cytochromes b5; Dapsone; Humans; Hydrogen-Ion Concentration; Microsomes, Liver; Oxidation-Reduction; Sulfamethoxazole; Swine | 2005 |
Reactive oxygen species generation and its role in the differential cytotoxicity of the arylhydroxylamine metabolites of sulfamethoxazole and dapsone in normal human epidermal keratinocytes.
Topics: Cells, Cultured; Dapsone; Epidermis; Humans; Hydroxylamine; Keratinocytes; Reactive Oxygen Species; Sulfamethoxazole | 2005 |
Role of human cyclooxygenase-2 in the bioactivation of dapsone and sulfamethoxazole.
Topics: Arachidonic Acid; Chromatography, High Pressure Liquid; Cyclooxygenase 2; Dapsone; Dose-Response Relationship, Drug; Edetic Acid; Enzyme-Linked Immunosorbent Assay; Hemin; Humans; Hydrogen Peroxide; Hydroxylamines; Protein Binding; Sulfamethoxazole | 2006 |
Effect of pro-inflammatory cytokines on the toxicity of the arylhydroxylamine metabolites of sulphamethoxazole and dapsone in normal human keratinocytes.
Topics: Anti-Infective Agents; Cell Death; Cells, Cultured; Dapsone; Glutathione; Humans; Hydroxylamines; Interferon-gamma; Interleukin-1; Keratinocytes; Lipopolysaccharides; Protein Binding; Reactive Oxygen Species; Sulfamethoxazole; Tumor Necrosis Factor-alpha | 2006 |
Bioactivation, protein haptenation, and toxicity of sulfamethoxazole and dapsone in normal human dermal fibroblasts.
Topics: Anti-Infective Agents; Arylamine N-Acetyltransferase; Cells, Cultured; Dapsone; Dose-Response Relationship, Drug; Drug Eruptions; Epidermal Cells; Epidermis; Fibroblasts; Haptens; Humans; Isoenzymes; Oxidative Stress; RNA, Messenger; Sulfamethoxazole | 2006 |
Enzyme-mediated protein haptenation of dapsone and sulfamethoxazole in human keratinocytes: II. Expression and role of flavin-containing monooxygenases and peroxidases.
Topics: Cells, Cultured; Dapsone; Haptens; Humans; Iodide Peroxidase; Keratinocytes; Lactoperoxidase; Oxygenases; Peroxidase; Peroxidases; Sulfamethoxazole | 2006 |
Enzyme-mediated protein haptenation of dapsone and sulfamethoxazole in human keratinocytes: I. Expression and role of cytochromes P450.
Topics: Acetylation; Cells, Cultured; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dapsone; Haptens; Humans; Keratinocytes; Sulfamethoxazole | 2006 |
A rapid assay for dihydropteroate synthase activity suitable for identification of inhibitors.
Topics: Dapsone; Dihydropteroate Synthase; Enzyme Activation; Enzyme Inhibitors; Models, Biological; NADP; Pterins; Reproducibility of Results; Spectrophotometry; Sulfachlorpyridazine; Sulfamethoxazole; Tetrahydrofolate Dehydrogenase | 2007 |
Formation and uptake of arylhydroxylamine-haptenated proteins in human dendritic cells.
Topics: Biological Transport; Biotransformation; Cell Differentiation; Cell Line; Dapsone; Dendritic Cells; Enzyme-Linked Immunosorbent Assay; Haptens; Humans; Microscopy, Confocal; Oxygenases; Peroxidase; Protein Binding; Proteins; Serum Albumin, Bovine; Sulfamethoxazole; Time Factors | 2007 |
Effect of arylhydroxylamine metabolites of sulfamethoxazole and dapsone on stress signal expression in human keratinocytes.
Topics: Cells, Cultured; Cytokines; Dapsone; Heat-Shock Proteins; Humans; Hydroxylamines; Immunity, Innate; Intercellular Adhesion Molecule-1; Keratinocytes; Microscopy, Fluorescence; Sulfamethoxazole; Uric Acid | 2007 |
Use of bacterial surrogates as a tool to explore antimalarial drug interaction: Synergism between inhibitors of malarial dihydrofolate reductase and dihydropteroate synthase.
Topics: Antimalarials; Dapsone; Dihydropteroate Synthase; Drug Interactions; Drug Resistance; Drug Synergism; Escherichia coli; Folic Acid Antagonists; Malaria, Falciparum; Organisms, Genetically Modified; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfamethoxazole; Tetrahydrofolate Dehydrogenase | 2015 |